Last reviewed · How we verify
NCT06635642: ARCHIVE
Auditory Research in Children Living With HIV Exposure-uninfected (ARCHIVE)
NA trial testing Dichotic Interaural Intensity Difference (DIID) Training in Hearing Loss. Withdrawn.
31 March 2030
Quick facts
| Lead sponsor | San Diego State University |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Start date | 1 January 2026 |
| Primary completion | 31 March 2030 |
| Estimated completion | 31 March 2030 |
Drugs / interventions tested
- Dichotic Interaural Intensity Difference (DIID) Training
Conditions studied
- Hearing Loss — all drugs for Hearing Loss →
Sponsor
San Diego State University
Who can join
Adults 7 to 9, any sex, with Hearing Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the association of in utero antiretroviral therapy (ART) exposure and hearing abilities of children who were perinatally HIV-exposed, but HIV-free, stratified by timing of maternal ART initiation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06635642
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hearing Loss
Currently open trials in the same condition.
- NCT07176936 — Improving Speech in Noise Using Noninvasive Stimulation · NA · recruiting
- NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene · NA · recruiting
- NCT07218913 — Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III · Phase 1 · recruiting
- NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit · NA · recruiting
- NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms · NA · recruiting
Other San Diego State University trials
Trials by the same sponsor.
- NCT06900634 — Pilot of an Intervention to Reduce Alcohol Use and Improve ART Adherence Among Men Living With HIV With Pregnant Partner · NA · not yet recruiting
- NCT07271290 — Preventing Noise Exposure in Farmworkers · NA · not yet recruiting
- NCT07010133 — Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers (Aim 3) · NA · not yet recruiting
- NCT06753123 — Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers (Aim 2) · NA · not yet recruiting
- NCT07290361 — Stratified Targeted Engagement From Primary Care to Physical Therapy (STEPPT) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06635642 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by San Diego State University
- Last refreshed: 14 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06635642.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing